Andrew Borkowski

2.2k total citations
39 papers, 1.5k citations indexed

About

Andrew Borkowski is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew Borkowski has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew Borkowski's work include Cancer-related Molecular Pathways (7 papers), Urinary Bladder and Prostate Research (6 papers) and Artificial Intelligence in Healthcare and Education (5 papers). Andrew Borkowski is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Urinary Bladder and Prostate Research (6 papers) and Artificial Intelligence in Healthcare and Education (5 papers). Andrew Borkowski collaborates with scholars based in United States, Cyprus and Australia. Andrew Borkowski's co-authors include Natasha Kyprianou, Stephen C. Jacobs, Yanping Guo, Andrew Kramer, Geoffrey N. Sklar, Natasha Kyprianou, Joanna K. Chon, Pradip Amin, Richard B. Alexander and John T. Isaacs and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Andrew Borkowski

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Borkowski United States 20 597 439 382 244 242 39 1.5k
Nathalie Nicolaı̈ew France 19 418 0.7× 726 1.7× 158 0.4× 220 0.9× 185 0.8× 25 1.3k
Takehiko Segawa Japan 18 600 1.0× 642 1.5× 190 0.5× 225 0.9× 80 0.3× 61 1.3k
Frank Perabo Germany 23 476 0.8× 638 1.5× 308 0.8× 385 1.6× 92 0.4× 71 1.5k
Hiroshi Eto Japan 28 963 1.6× 596 1.4× 513 1.3× 432 1.8× 145 0.6× 96 2.5k
Rainy Umbas Indonesia 19 1.3k 2.1× 798 1.8× 443 1.2× 373 1.5× 106 0.4× 68 2.2k
Kohei Kurokawa Japan 20 262 0.4× 545 1.2× 218 0.6× 74 0.3× 165 0.7× 70 1.1k
Katsunori Tatsugami Japan 28 852 1.4× 1.2k 2.8× 590 1.5× 469 1.9× 112 0.5× 138 2.3k
Gary J. Smith United States 25 785 1.3× 579 1.3× 471 1.2× 333 1.4× 39 0.2× 74 1.8k
Ario Takeuchi Japan 24 765 1.3× 913 2.1× 512 1.3× 415 1.7× 34 0.1× 114 1.9k
Xiaodong Teng China 24 716 1.2× 482 1.1× 397 1.0× 260 1.1× 24 0.1× 116 1.7k

Countries citing papers authored by Andrew Borkowski

Since Specialization
Citations

This map shows the geographic impact of Andrew Borkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Borkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Borkowski more than expected).

Fields of papers citing papers by Andrew Borkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Borkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Borkowski. The network helps show where Andrew Borkowski may publish in the future.

Co-authorship network of co-authors of Andrew Borkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Borkowski. A scholar is included among the top collaborators of Andrew Borkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Borkowski. Andrew Borkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borkowski, Andrew. (2025). Multiagent AI Systems in Health Care: Envisioning Next-Generation Intelligence. Federal Practitioner. 42(5). 188–194. 2 indexed citations
2.
Makridis, Christos, et al.. (2024). From theory to practice: Harmonizing taxonomies of trustworthy AI. SHILAP Revista de lepidopterología. 7. 100128–100128. 2 indexed citations
3.
Makridis, Christos, Andrew Borkowski, & Gil Alterovitz. (2024). Perspectives on advancing innovation and human flourishing through a network of AI institutes. Science and Public Policy. 51(3). 557–562. 3 indexed citations
4.
Bui, Marilyn M., Eric F. Glassy, Issam El Naqa, et al.. (2023). Revolutionizing Digital Pathology With the Power of Generative Artificial Intelligence and Foundation Models. Laboratory Investigation. 103(11). 100255–100255. 56 indexed citations
5.
Borkowski, Andrew. (2023). Applications of ChatGPT and Large Language Models in Medicine and Health Care: Benefits and Pitfalls. Federal Practitioner. 40(6). 170–173. 17 indexed citations
6.
Mayfield, John D., et al.. (2023). Pilot Lightweight Denoising Algorithm for Multiple Sclerosis on Spine MRI. Journal of Digital Imaging. 36(4). 1877–1884. 1 indexed citations
7.
Borkowski, Andrew, et al.. (2023). Artificial Intelligence for Clinical Flow Cytometry. Clinics in Laboratory Medicine. 43(3). 485–505. 5 indexed citations
8.
Borkowski, Andrew. (2022). Establishing a Hospital Artificial Intelligence Committee to Improve Patient Care. Federal Practitioner. 39(39 (8)). 334–336. 7 indexed citations
9.
Borkowski, Andrew. (2020). Using Artificial Intelligence for COVID-19 Chest X-ray Diagnosis. Federal Practitioner. 37(Vol 37 No 9). 398–404. 46 indexed citations
10.
Borkowski, Andrew, et al.. (2014). Warfarin Pharmacogenomics: Recommendations With Available Patented Clinical Technologies. Recent Patents on Biotechnology. 8(2). 110–115. 6 indexed citations
11.
Atiemo, Humphrey, et al.. (2006). Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells. The Prostate. 66(11). 1194–1202. 21 indexed citations
12.
Kimos, Martha, Suna Wang, Andrew Borkowski, et al.. (2004). Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. International Journal of Cancer. 111(3). 415–417. 48 indexed citations
13.
Glassman, Deborah T., Joanna K. Chon, Andrew Borkowski, Stephen C. Jacobs, & Natasha Kyprianou. (2001). Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-? expression in benign prostatic hyperplasia. The Prostate. 46(1). 45–51. 63 indexed citations
14.
Borkowski, Andrew, et al.. (2001). Intranet-Based Quality Improvement Documentation at the Veterans Affairs Maryland Health Care System. Modern Pathology. 14(1). 1–5. 4 indexed citations
15.
Keledjian, Kaspar, Andrew Borkowski, Grace Kim, et al.. (2001). Reduction of human prostate tumor vascularity by the α1‐adrenoceptor antagonist terazosin. The Prostate. 48(2). 71–78. 29 indexed citations
16.
Kramer, Andrew, et al.. (2001). Loss of caspase-1 and caspase-3 protein expression in human prostate cancer.. PubMed. 61(3). 1227–32. 181 indexed citations
17.
Guo, Yanping, et al.. (2000). Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients. The Prostate. 42(2). 130–136. 39 indexed citations
18.
Pizzo, Joseph J. Del, Andrew Borkowski, Stephen C. Jacobs, & Natasha Kyprianou. (1999). Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient Survival. American Journal Of Pathology. 155(4). 1129–1136. 83 indexed citations
19.
Pizzo, Joseph J. Del, Andrew Borkowski, Stephen C. Jacobs, & Natasha Kyprianou. (1999). LOSS OF CELL-CYCLE REGULATORS p27Kip1 AND CYCLIN E IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER CORRELATES WITH TUMOR GRADE AND PATIENT SURVIVAL. The Journal of Urology. 117–117. 1 indexed citations
20.
Borkowski, Andrew, et al.. (1998). bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology. 52(6). 1085–1090. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Nicolaı̈ew Breakdown of academic impact, for papers by Takehiko Segawa Breakdown of academic impact, for papers by Frank Perabo Breakdown of academic impact, for papers by Hiroshi Eto Breakdown of academic impact, for papers by Rainy Umbas Breakdown of academic impact, for papers by Kohei Kurokawa Breakdown of academic impact, for papers by Katsunori Tatsugami Breakdown of academic impact, for papers by Gary J. Smith Breakdown of academic impact, for papers by Ario Takeuchi Breakdown of academic impact, for papers by Xiaodong Teng
Rankless by CCL
2026